Chatterjee Mary, Sil Parames C
Department of Chemistry, Bose Institute, 93/1, Acharya Prafulla Chandra Road Kolkata-700009, India.
Indian J Biochem Biophys. 2006 Oct;43(5):299-305.
Nimesulide (NIM), an atypical non-steroidal anti-inflammatory drug (NSAID) is also used as analgesic. In the present study, we evaluated its effect on the prooxidant-antioxidant system of liver and the hepatoprotective potential of aqueous extract of the herb Phyllanthus niruri (PN) on NIM-induced oxidative stress in vivo using a murine model, by determining the activities of hepatic anti-oxidant enzymes superoxide dismutase (SOD) and catalase (CAT), levels of reduced glutathione (GSH) and lipid peroxidation (expressed as malonaldialdehyde, MDA). Aqueous extract of PN at a dose of 50 or 100 mg/kg body wt was administered either intraperitoneally or orally for 7 days, before NIM administration at a dose of 8 mg/kg body wt twice daily for 7 days in mice. Animals were sacrificed 24 h after administration of final dose of NIM. In another set of experiments, both aqueous extract of PN (at a dose of 50 or 100 mg/kg body wt) and NIM (8 mg/kg body wt) were administered simultaneously for 7 days. Animals were sacrificed 24 h after administration of final dose of the extract and NIM, liver tissues were collected, and the activities of SOD and CAT and levels of GSH and lipid peroxidation end-product (as MDA), were determined from the livers of all the experimental animals. Appropriate NIM control was maintained for all sets of experiments. NIM administration (8 mg/kg body wt) for 7 days caused significant depletion of the levels of SOD, CAT and reduced GSH, along with the increased levels of lipid peroxidation. Intraperitoneal administration of the extract at a dose of 50 mg/kg body wt for 7 days,. prior to NIM treatment, significantly restored most of the NIM-induced changes and the effect was comparable to that obtained by administering 100 mg/kg body wt of the extract orally. Thus, results suggested that intraperitoneal administration of the extract could protect liver from NIM-induced hepatic damage more effectively than oral administration. Antioxidant property of the aqueous extract of PN was also compared with that of a known potent antioxidant, vitamin E. The PN extract at a dose of 100 mg/kg body wt along with NIM was more effective in suppressing the oxidative damage than the PN extract at a dose of 50 mg/kg body wt. Results suggested that beneficial effect of the aqueous extract of PN, probably through its antioxidant property, might control the NIM-induced oxidative stress in the liver.
尼美舒利(NIM)是一种非典型非甾体抗炎药(NSAID),也用作镇痛药。在本研究中,我们使用小鼠模型,通过测定肝脏抗氧化酶超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性、还原型谷胱甘肽(GSH)水平和脂质过氧化(以丙二醛,MDA表示),评估了其对肝脏促氧化-抗氧化系统的影响以及草药叶下珠(PN)水提取物对NIM诱导的体内氧化应激的肝保护潜力。在以8mg/kg体重的剂量每天两次给小鼠施用NIM 7天之前,以50或100mg/kg体重的剂量腹膜内或口服给予PN水提取物7天。在给予最后一剂NIM 24小时后处死动物。在另一组实验中,同时给予PN水提取物(50或100mg/kg体重的剂量)和NIM(8mg/kg体重)7天。在给予提取物和NIM的最后一剂24小时后处死动物,收集肝脏组织,并测定所有实验动物肝脏中SOD和CAT的活性以及GSH和脂质过氧化终产物(如MDA)的水平。对所有实验组均维持适当的NIM对照。以8mg/kg体重的剂量施用NIM 7天导致SOD、CAT水平和还原型GSH显著消耗,同时脂质过氧化水平升高。在NIM治疗前,以50mg/kg体重的剂量腹膜内给予提取物7天,显著恢复了大部分NIM诱导的变化,其效果与口服100mg/kg体重的提取物相当。因此,结果表明腹膜内给予提取物比口服更能有效地保护肝脏免受NIM诱导的肝损伤。还将PN水提取物的抗氧化性能与已知的强效抗氧化剂维生素E进行了比较。与50mg/kg体重剂量的PN提取物相比,100mg/kg体重剂量的PN提取物与NIM一起更有效地抑制氧化损伤。结果表明,PN水提取物的有益作用可能通过其抗氧化性能来控制NIM诱导的肝脏氧化应激。